Gelone Steven P. 4
4 · Nabriva Therapeutics plc · Filed Jan 10, 2023
Insider Transaction Report
Form 4
Gelone Steven P.
Chief Development Officer
Transactions
- Tax Payment
Ordinary Shares
2023-01-06$1.30/sh−5$7→ 14,423 total
Footnotes (1)
- [F1]These ordinary shares were withheld by the Issuer in order to satisfy tax withholding obligations upon the vesting of certain restricted share units.